This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
ADC Therapeutics SA
Drug Names(s): ADCT 501, ADCT501
Description: ADCT-501 is an antibody-conjugate under development by ADC Therapeutics.
Additional information available to subscribers only: